MF

Manning Family Foundation

North America, Virginia, United States, Charlottesville

Description

Manning Family Foundation advances health and healthy communities by awarding grants to nonprofit organizations.

Investor Profile

Manning Family Foundation has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Therapeutics.

Stage Focus

  • Series A (33%)
  • Seed (33%)
  • Series C (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Health Diagnostics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Manning Family Foundation frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 2
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Co-Investments: 2
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
University of Florida
North America, Florida, United States, Gainesville
Co-Investments: 1
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Foundation Fighting Blindness
North America, Maryland, United States, Columbia
Co-Investments: 1

What are some of recent deals done by Manning Family Foundation?

Atsena Therapeutics

Durham, North Carolina, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

BiotechnologyHealth CareTherapeutics
Series CApr 2, 2025
Amount Raised: $150,000,000
Opus Genetics

Raleigh, North Carolina, United States

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.

Health CareHealth DiagnosticsWellness
SeedSep 22, 2021
Amount Raised: $19,000,000
Atsena Therapeutics

Durham, North Carolina, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

BiotechnologyHealth CareTherapeutics
Series ADec 16, 2020
Amount Raised: $55,000,000